1Gaetani P,Silvani V,Butti G,et al.Nitrosourea derivatives induced pulmonary toxicity in patients treated for malignant brain tumors.Early Sub clinical detection and its prevention[J].Eur J Clin Oneol,1987,23(5):267-271.
4Wauer RR,Schmalisch G,Boehme B,et al.Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome[J].Eur J Pedistr,1992,151:357-363.
4Miracle X, Di Renzo GC, Stark A, Fanaroff A, Carbonell-Estrany X, Salir.g E. Guideline for the use of antenatal corticosteroids for fetal m2turation[J]. J Perinat Med,2008,3ta(2):191-196.
5Jobe AH. Pulmonary. surfactant therapy[J]. N Engl J Med,1993,325(8):861-868.
6Henderson-Smart DJ, Witkins9n A, Raynes-Greenow CH. Mechan-ical ventilation for newborn irfants with respiratory failure due to pulmonary disease[DB/OL]. Cochrane Database Syst Rev, 2002,(4):CD002170.
7Soll RF, Morley CJ. Prophylactic versus celective use of surfactant in preventing morbidity and mortality in preterm infanls[DB/OL]. Cochrane Syst Rev, 2001,(2):CD00510.
8Disse BG, Ziegler HW. Phannacodynamic mechanism and thera-peutic activity of ambroxol in animal experiments[J]. Respiration,1987,5! (Supp! 1) :15-22.
9Allegra L, Bossi R, Braga P. Influence of surfactant on mucocili- ary transport [J]. Eur J Respir Dis,1985,67(Suppl 142):71-76.
10Rober3on B. Pharmacological stimulation of surfactant secretion and surfactant replacement[J]. Eur J Respir Dis,1955,67(Sup-pl 142):63-70.
